专题：Health Systems, Economic Evaluations, Quality of Life

This cluster of papers focuses on the intersection of health economics and quality of life assessment, with a particular emphasis on cost-effectiveness analysis, health utility measures such as EQ-5D and SF-36, quality-adjusted life years (QALY), health technology assessment, and preference-based measures for evaluating the economic impact of healthcare interventions.
最新文献
Trends in County-Level Childhood Vaccination Exemptions in the US

article Full Text OpenAlex

Are prioritizing and allocating expensive adjuvant and maintenance therapies beneficial in cancer care?

article Full Text OpenAlex

Oral triple combination lipid-lowering therapy and LDL cholesterol goal attainment: a simulation using the SANTORINI study cohort

article Full Text OpenAlex

Predictive Modeling for Portfolio Risk Assessment in Multi-Therapeutic Pharmaceutical Enterprises

article Full Text OpenAlex

Determining the value of genomics in healthcare

article Full Text OpenAlex

Setting priorities for healthcare interventions in Indonesia: a comprehensive conceptual framework

article Full Text OpenAlex

SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials

review Full Text OpenAlex

Study Designs and Methods for Health Policy and Health Services Research

article Full Text OpenAlex

FDA’s New Plausible Mechanism Pathway

article Full Text OpenAlex

Collective international action to increase access to costly drugs: pooled procurement and equity based tiered pricing

article Full Text OpenAlex

近5年高被引文献
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

article Full Text OpenAlex 4933 FWCI635.0877

2023 Alzheimer's disease facts and figures

article Full Text OpenAlex 3018 FWCI617.6924

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

article Full Text OpenAlex 2353 FWCI1251.8586

Multimorbidity

review Full Text OpenAlex 1246 FWCI174.33

American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults

article Full Text OpenAlex 1223 FWCI206.106

Chronic kidney disease and the global public health agenda: an international consensus

review Full Text OpenAlex 1032 FWCI849.5594

The Overview on Effectiveness of Quality Enhancement for Enhancing Health Care and Professional Practice

article Full Text OpenAlex 959 FWCI1045.1015

The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials

article Full Text OpenAlex 957 FWCI234.0885

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

review Full Text OpenAlex 942 FWCI227.9264

Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

article Full Text OpenAlex 887 FWCI471.1753